MedPath

Effect of different depths of microneedling with tranexamic acid in melasma

Not Applicable
Conditions
Health Condition 1: L811- Chloasma
Registration Number
CTRI/2024/01/061450
Lead Sponsor
Department of Dermatology government medical college and hospital chandigarh
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

nil

Exclusion Criteria

Patients with known bleeding diathesis.

Patient taking anticoagulants, estrogen, progesterone, and antiandrogens.

Pregnant and lactating mothers.

Patients with any systemic illness

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To calculate and compare hemiMASI of both sides of face at each visit to assess the melasmaTimepoint: 0,2,4,6,10 weeks
Secondary Outcome Measures
NameTimeMethod
side effects of dermarolling will be assessed & compared on both sides of face at 0,2,4,6,10 weeksTimepoint: baseline 2 weeks 4 weeks 6 weeks 4 weeks follow up
© Copyright 2025. All Rights Reserved by MedPath